False-negative or false-positive: Laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: A rebuttal

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 7, 2011, Pages 1435-1436

  Tripodi, A ^a   Moia, M ^a   Pengo, V ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; HEPARIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PROTHROMBIN; THROMBOPLASTIN;

ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; LETTER; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE;

EID: 79959846526     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04284.x     Document Type: Letter

References (10)

1. Aboud M, Morel-Kopp MC, Ward C, Coyle L. False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant. J Thromb Haemost 2010; 8: 2070-3.
2. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737-40.
3. Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano-D'Angelo S, Grazia Sabbadini M, D'Angelo A. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Med Interne 1996; 147 (Suppl. 1): 10-14.
4. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997; 127: 177-85.
5. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 1997; 98: 887-92.
6. Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol 2001; 115: 672-8.
7. Robert A, Le Querrec A, Delahousse B, Caron C, Houbouyan L, Boutière B, Horellou MH, Reber G, Sié P. Control of oral anticoagulation in patients with the antiphospholipid syndrome - influence of the lupus anticoagulant on International Normalized Ratio. Thromb Haemost 1998; 80: 99-103.
8. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl.): 160S-98S.
9. Tripodi A, de Groot PG, Pengo V. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J Intern Med 2011; DOI:.
10. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010; 8: 237-42.